Published on : Aug 28, 2019
Orthopedic surgical robots will improve the quality of knee and hip surgery by leaps and bounds. This is because robotic capability supports a higher precision in surgery than what was previously available. Knee arthroplasty that is carried out with the help of surgical robots offers several benefits such as less bleeding, low intensity of post-operative pain, faster recovery, and less re-admissions to hospital after the surgery.
Surgical robots offer other advantages as well. These include surgical precision that can be reproduced over and over, which is not attainable is human-driven surgical procedures. Due to this capability, robots are poised to become the defacto standard for knee and hip surgery in the forthcoming years. It is anticipated that individuals seeking hip or knee replacement will demand the attention of the clinician to maintain quality of life by means of robot assisted surgeries.
The report elucidates the reasons for the consistently increasing popularity of robot-assisted orthopedic surgeries across the world. First and foremost, the ever-increasing geriatric population in the U.S., which is vulnerable to health issues, holds promise for the adoption of orthopedic surgical robots in the years to come. The aging population in other parts of the world is anticipated to bolster the growth of these markets in the future.
Request a Sample PDF copy with detailed Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=2435502
On the region, the orthopedic surgical robots market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Of these, Asia Pacific is expected to dominate the global orthopedic surgical robots market. This is attributable to the growing investment in the healthcare industry globally.
Some of the key players operating in the orthopedic surgical robots market are Intuitive Surgical, Inc., Medtronic Plc., Stryker Corporation, Zimmer Biomet, Smith & Nephew plc., Globus Medical, Inc., Mazor Robotics, Wright Medical Group N.V., Accuray Incorporated, and Johnson & Johnson Services, Inc.